Eosinophilic otitis media and eosinophilic asthma: Shared pathophysiology and response to anti-IL5
Main Article Content
Article Details
Copyright (c) 2019 Drijver-Messelink MT, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006; 368(9537): 804-813. Ref.: https://bit.ly/2WAWGAQ
Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.
Lancet. 2008; 372(9643): 1107-1119. Ref.: https://bit.ly/2QCRxTe
de Groot JC, Ten Brinke A, Bel EH. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 2015; 1. Ref.: https://bit.ly/2Mqurkg
de Groot JC, Storm H, Amelink M, de Nijs SB, Eichhorn E, et al. Clinical profile of patients with adult-onset eosinophilic asthma. ERJ Open Res. 2016; 2: 00100-2015. Ref.: https://bit.ly/2KnQohx
Russell R, Brightling CE. Anti-IL-5 for Severe Asthma: Aiming High to Achieve Success. Chest. 2016; 150: 766-768. Ref.: https://bit.ly/2XmSWQD
Bel EH, ten Brinke A. New Anti-Eosinophil Drugs for Asthma and COPD. Targeting the trait! Chest. 2017; 152: 1276-1282. Ref.: https://bit.ly/2Wqtnlm
van der Meer AN, ten Brinke A. Nasal polyposis and asthma: the chest physician’s view. In: Bachert C, Bourdin A, Chanez P, eds. The Nose and Sinuses in Respiratory Disorders (ERS Monograph). Sheffield, European Respiratory Society. 2017; 105–121. Ref.: https://bit.ly/2WlP4ms
Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011; 38: 456-461. Ref.: https://bit.ly/2If8QGp
Ueki S, Ohta N, Takeda M, Konno Y, Hirokawa M. Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.
Curr Allergy Asthma Rep. 2017; 17:33. Ref.: https://bit.ly/2QHSARQ